Literature DB >> 10503751

Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.

B Basnyat1, J Lemaster, J A Litch.   

Abstract

BACKGROUND: Thousand of tourists trek in the Himalayas every season and risk acute mountain sickness (AMS). Prior studies have shown that the rate of ascent is one of the primary risk factors for the development of AMS but the role of body hydration, age, gender, alcohol and medication usage, body weight, and altitude of residence continues to be in question. This study estimates the incidence of AMS at 4234 m at Pheriche in the Everest region, explores a number of risk factors predisposing trekkers to a diagnosis of AMS and attempts to quantify the relationship between the Lake Louise AMS diagnostic criteria and oxygen saturation.
METHODS: Demographic data and information about risk factors felt to place trekkers at increased risk of AMS was collected from 550 trekkers for 1 mo in the fall of 1996 at 4234 m in the Everest region.
RESULTS: Diagnosis of AMS was made in 29.8% (159 trekkers) of the study population. Low water intake (odds ratio 1.57; 95% confidence interval,1.02-2.40), the presence of respiratory symptoms (odds ratio 2.21; 95% confidence interval, 1.43-3.40), and an oxygen saturation below 85% at 4243 m (odds ratio 2.35; 95% confidence interval, 1.55-3.56) were identified as independent risk factors for AMS diagnosis in this sample. In addition, AMS risk decreased 18.7% (95% confidence interval, 3.8-31.2%) for each additional night spent between Lukla (2804 m) and the study site at 4243 m.
CONCLUSION: Increased reported fluid intake decreased the risk of AMS in this cross sectional prospective study. Further studies need to be done to confirm this finding before recommendations can be made. In addition the rise in the risk of AMS as the rate of ascent increased along this popular Everest trek was quantified for the first time. Finally, AMS was also associated with respiratory symptoms and with a lower oxygen saturation.

Entities:  

Mesh:

Year:  1999        PMID: 10503751

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  15 in total

1.  Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.

Authors:  Pamela L Johnson; Claire C Johnson; Prasanta Poudyal; Nirajan Regmi; Megan A Walmsley; Buddha Basnyat
Journal:  High Alt Med Biol       Date:  2013-09       Impact factor: 1.981

Review 2.  High altitude pilgrimage medicine.

Authors:  Buddha Basnyat
Journal:  High Alt Med Biol       Date:  2014-12       Impact factor: 1.981

Review 3.  Injuries in extreme sports.

Authors:  Lior Laver; Ioannis P Pengas; Omer Mei-Dan
Journal:  J Orthop Surg Res       Date:  2017-04-18       Impact factor: 2.359

4.  Three-Minute Step Test for Predicting Acute Mountain Sickness: A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Authors:  Hsiang Yun Lo; Lisa Li-Chuan Chen; Deng-Huang Su; Chung-Hsien Chen; Tai-Yi Hsu; Shih-Hao Wang; Yi-Ming Weng; Cheng-Wei Chan; Shih-Hao Wu; Hang-Cheng Chen; Te-Fa Chiu
Journal:  J Acute Med       Date:  2018-03-01

5.  Hypertension and Acute Mountain Sickness in Himalayan Trekkers in Nepal: An Observational Cohort Study.

Authors:  Charles B Duke; T Douglas Sallade; Jennifer Starling; Sushil Pant; Alison Sheets; Matthew K McElwee; David S Young; Richard Andrew Taylor; Linda E Keyes
Journal:  Wilderness Environ Med       Date:  2020-03-21       Impact factor: 1.518

6.  Association between body water status and acute mountain sickness.

Authors:  Hannes Gatterer; Maria Wille; Martin Faulhaber; Henry Lukaski; Andreas Melmer; Christoph Ebenbichler; Martin Burtscher
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

7.  Bioelectrical Impedance Vector Analysis: A Valuable Tool to Monitor Daily Body Hydration Dynamics at Altitude.

Authors:  Ivo B Regli; Rachel Turner; Simon Woyke; Simon Rauch; Hermann Brugger; Hannes Gatterer
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

8.  A prospective epidemiological study of acute mountain sickness in Nepalese pilgrims ascending to high altitude (4380 m).

Authors:  Martin J MacInnis; Eric A Carter; Michael G Freeman; Bidur Prasad Pandit; Ashmita Siwakoti; Ankita Subedi; Utsav Timalsina; Nadia Widmer; Ghan Bahadur Thapa; Michael S Koehle; Jim L Rupert
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

9.  Acute mountain sickness among tourists visiting the high-altitude city of Lhasa at 3658 m above sea level: a cross-sectional study.

Authors:  Per Nafstad; Hein Stigum; Tianyi Wu; Øyvind Drejer Haldorsen; Kristoffer Ommundsen; Espen Bjertness
Journal:  Arch Public Health       Date:  2016-06-01

10.  Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema.

Authors:  Matthias Peter Hilty; Stefanie Zügel; Michele Schoeb; Katja Auinger; Christoph Dehnert; Marco Maggiorini
Journal:  Mediators Inflamm       Date:  2016-06-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.